Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Opis bibliograficzny
1. autor:	Rahman, Tasnim
Kolejni autorzy:	Azam, Faruque
Format:	Praca dyplomowa
Język:	English
Wydane:	Brac University 2024
Hasła przedmiotowe:	Efficacy endpoint Clinical trial Treatment size Lung cancer Lung > Cancer > Treatment
Dostęp online:	http://hdl.handle.net/10361/22174

Podobne zapisy

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
od: Paul, Pulock
Wydane: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Flora, Sanzida Alam
Wydane: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
od: Hoque, Ismoth Ara
Wydane: (2024)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Karim, Samia Binte
Wydane: (2024)

Potential of liposomes for the treatment of lung cancer- a review
od: Mim, Shanzida
Wydane: (2023)

A review on targeted therapies for lung cancer
od: Ashraf, Anushey
Wydane: (2023)

A review on recent advances in drugs for lung cancer treatment
od: Noor, Fouzia
Wydane: (2024)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
od: Zangmo, Thinley
Wydane: (2024)

Molecules associated with the development of lung cancer
od: Rahman, Adree, i wsp.
Wydane: (2023)

Protein biomarkers for Lung Cancer: a bioinformatic approach
od: Jeba, Joynob
Wydane: (2017)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
od: Tania, Umme
Wydane: (2023)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
od: Shobnam, Sohana
Wydane: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
od: Razna, Amrin Islam
Wydane: (2019)

Immunotherapy in the Management of Lung Cancer
od: Tasnim, Humayra
Wydane: (2022)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
od: Pial, Sazia Afrin
Wydane: (2018)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
od: Das, Reshita
Wydane: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
od: Bristy, Israt Zerin
Wydane: (2021)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
od: Shabnam, Musharrat
Wydane: (2018)

Current practice and approaches of immunotherapy in Cancer treatment
od: Khondokar, Faiza
Wydane: (2022)

Biosimilar in lymphoma treatment
od: Tanisha, Mehrin Haque
Wydane: (2021)

Lung cancer detection and classification using machine learning
od: Arefin, Mahbubul, i wsp.
Wydane: (2023)

Recent advancement on breast cancer detection and treatment
od: Rahman, Sanjida
Wydane: (2023)

Targeting BRAFV600E in the treatment of CRC
od: Roja, Mashwiyat Samrin
Wydane: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
od: Jahan, Nusrat
Wydane: (2024)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
od: Mukti, Roushney Fatima, i wsp.
Wydane: (2016)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
od: Nandy, Aditi
Wydane: (2022)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
od: Muntaha, Habibatul
Wydane: (2023)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
od: Rahman, Qazi Ashrafur
Wydane: (2018)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
od: Hossain, Safa Binte
Wydane: (2019)

ক্যান্সার : মৃত্যু অবধারিত নয় /
od: করীম, আবুল বাশার মোহাম্মদ ফজলুল

Dendritic cell vaccine for the treatment of cancer
od: Haque, Tanzila
Wydane: (2023)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
od: Shaikat, Mahdi Mubin
Wydane: (2023)

A comprehensive review on drug repurposing in cancer treatment
od: Sarkar, Onusree
Wydane: (2024)

Stem cells as therapeutic carrier in cancer treatment
od: Anika, Mysha Yeasmin
Wydane: (2022)

A review on non-polyphenolic and terpenoid phytoconstituents with antioxidant and cytotoxic potential
od: Ahmed, Kazi Zeba
Wydane: (2021)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
od: Hasan, Sakib
Wydane: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
od: Nahar, Kamrun
Wydane: (2023)

Natural products and their combinatory effects in breast cancer treatment
od: Siddique, Md. Ayman
Wydane: (2021)

Targeted therapeutic options in the treatment of Breast Cancer
od: Alam, Kazi Tasnuva
Wydane: (2022)

A review on artemisinin based combination therapy for the treatment of Malaria
od: Chowdhury, Amina Ferdous
Wydane: (2020)